KIDNEY TRANSPLANT
Clinical trials for KIDNEY TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can the HPV vaccine protect transplant patients? new study investigates
⭐️ VACCINE ⭐️ OngoingThis study looks at how well the HPV9 vaccine (Gardasil 9) works in people who have had a kidney transplant. Researchers will measure antibody levels in 30 transplant recipients over 24 months and compare them to published data from healthy individuals. The goal is to see if the …
Matched conditions: KIDNEY TRANSPLANT
Phase: PHASE4 • Sponsor: Medical College of Wisconsin • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:28 UTC
-
New hope for transplant patients: drug targets kidney protein leak
Disease control OngoingThis study tests a drug called sparsentan for people who have protein in their urine after a kidney transplant due to IgA nephropathy or FSGS. About 20 adults will take the drug once daily for 36 weeks to see if it safely reduces protein levels and protects kidney function. The g…
Matched conditions: KIDNEY TRANSPLANT
Phase: PHASE4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a single cell infusion replace lifelong Anti-Rejection drugs?
Disease control OngoingThis early-phase study tests whether a single infusion of special immune cells (regulatory dendritic cells) from the kidney donor can help the recipient's body accept the new kidney with fewer side effects. 14 first-time kidney transplant recipients will receive the cells one wee…
Matched conditions: KIDNEY TRANSPLANT
Phase: PHASE1 • Sponsor: Angus W. Thomson PhD DSc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common diabetes drug help transplanted kidneys survive longer?
Disease control OngoingThis study tests whether dapagliflozin, a drug usually used for diabetes, can improve kidney function in people who have received a kidney from a living donor. Fifty-four adult transplant recipients will take either dapagliflozin or standard care for 12 months. Researchers will m…
Matched conditions: KIDNEY TRANSPLANT
Phase: PHASE2 • Sponsor: University of Guadalajara • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Weight loss program aims to get obese patients off the inactive transplant list
Disease control OngoingThis study tests whether a 6-month exercise and personalized diet plan can help patients with obesity (BMI 40-44) lose weight so they can become active on the kidney transplant waiting list. Ten adults who are currently listed as 'inactive' due to their weight will follow a fitne…
Matched conditions: KIDNEY TRANSPLANT
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could testosterone boost kidney transplant success?
Disease control OngoingThis study looks at whether giving testosterone to men with low testosterone and kidney failure can help them recover better after a kidney transplant. About 50 men will receive testosterone before and after their transplant, and their safety and recovery will be compared to a si…
Matched conditions: KIDNEY TRANSPLANT
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Kidney transplant patients get genetic check for hidden cancer risks
Knowledge-focused OngoingThis study tests kidney transplant patients for genetic mutations that raise the risk of cancer and other diseases. Researchers want to see how common these mutations are and if testing helps guide better cancer screening. About 177 participants from Mayo Clinic are involved, all…
Matched conditions: KIDNEY TRANSPLANT
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Massive study aims to stop wasting donated kidneys worldwide
Knowledge-focused ENROLLING_BY_INVITATIONThis study tracks 300,000 donated kidneys from 2010 to 2025 across many countries. Researchers want to see why some kidneys are discarded and how to use them better. The goal is to help more people get transplants and reduce organ waste.
Matched conditions: KIDNEY TRANSPLANT
Sponsor: Paris Translational Research Center for Organ Transplantation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC